Cargando…
Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells
Background: Gastric cancer (GC) with peritoneal metastasis has an extremely poor prognosis. Paclitaxel (PTX) intraperitoneal infusion provides an effective treatment for these patients. However, GC patients with peritoneal metastasis who receiving PTX treatments tend to occur PTX-resistance accompan...
Autores principales: | Yang, Zhongyin, Yan, Chao, Yu, Zhenjia, He, Changyu, Li, Jianfang, Li, Chen, Yan, Min, Liu, Bingya, Wu, Yingli, Zhu, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738820/ https://www.ncbi.nlm.nih.gov/pubmed/33391403 http://dx.doi.org/10.7150/jca.48193 |
Ejemplares similares
-
Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription
por: Pan, Tao, et al.
Publicado: (2021) -
The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer
por: Jin, Zhijian, et al.
Publicado: (2021) -
Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation
por: Yao, Lizhong, et al.
Publicado: (2023) -
Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway
por: Wang, Xiaofeng, et al.
Publicado: (2016) -
The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer
por: QU, YING, et al.
Publicado: (2014)